Kura Oncology, Inc.
At Close: 4:00 PM
KURA Stock Price Graph
KURA Stock Price Today
Kura Oncology, Inc. (KURA) stock declined over -2.35% intraday to trade at $10.81 a share on NASDAQ. The stock opened with a loss of -29.56% at $7.96 and touched an intraday high of $8.09, falling -4.34% against the last close of $11.30. The Kura Oncology, Inc. in stock market went to a low of $7.62 during the session.
KURA Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
KURA Stock Price History Chart
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
Frequently Asked Questions
What is the current Kura Oncology, Inc. (KURA) stock price?
Kura Oncology, Inc. (NASDAQ: KURA) stock price is $10.81 in the last trading session. During the trading session, KURA stock reached the peak price of $8.09 while $7.62 was the lowest point it dropped to. The percentage change in KURA stock occurred in the recent session was -2.35% while the dollar amount for the price change in KURA stock was -$0.26.
KURA's industry and sector of operation?
The NASDAQ listed KURA is part of Biotechnology industry that operates in the broader Healthcare sector. Kura Oncology, Inc. , a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States.
Who are the executives of KURA?
Ms. Kirsten Flowers
Chief Commercial Officer & Chief Corporation Strategy Officer
Mr. Pete De Spain
Senior Vice President of Investor Relations & Corporation Communications
Mr. Thomas Doyle
Principal Accounting Officer & Senior Vice President of Fin. and Accounting
Ms. Teresa Brophy Bair Esq., J.D.
Chief Legal Officer & Corporation Sec.
How KURA did perform over past 52-week?
KURA's closing price is 0.18% higher than its 52-week low of $7.41 where as its distance from 52-week high of $16.37 is -0.44%.
How many employees does KURA have?
Number of KURA employees currently stands at N/A. KURA operates from 12730 High Bluff Drive, San Diego, CA 92130, US.
Link for KURA official website?
Official Website of KURA is: https://kuraoncology.com
How do I contact KURA?
How many shares of KURA are traded daily?
KURA stock volume for the day was 1015380.00 shares. The average number of KURA shares traded daily for last 3 months was 765.49 Thousands.
What is the market cap of KURA currently?
The market value of KURA currently stands at $802.86 Million with its latest stock price at $10.81 and N/A of its shares outstanding.